These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8125037)

  • 1. [Reinfection with Borrelia burgdorferi in an immunocompetent patient].
    Hassler D; Maiwald M
    Dtsch Med Wochenschr; 1994 Mar; 119(10):338-42. PubMed ID: 8125037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician-diagnosed erythema migrans and erythema migrans-like rashes following Lone Star tick bites.
    Masters E; Granter S; Duray P; Cordes P
    Arch Dermatol; 1998 Aug; 134(8):955-60. PubMed ID: 9722725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
    Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H
    Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningitis after acute Borrelia burgdorferi infection in HIV infection].
    Dudle G; Opravil M; Lüthy R; Weber R
    Dtsch Med Wochenschr; 1997 Sep; 122(39):1178-80. PubMed ID: 9378035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multilocular erythema migrans in borreliosis].
    Krischer S; Ott H; Barker M; Frank J; Erdmann S
    Klin Padiatr; 2004; 216(4):236-7. PubMed ID: 15284948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Borrelia burgdorferi, clinical aspects, cultivation and identification of the pathogen in erythema migrans in Berlin].
    Ott A; Schönberg A
    Z Hautkr; 1989 Aug; 64(8):644-8. PubMed ID: 2678789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rocky Mountain "spotless" fever with an erythema migrans-like skin lesion.
    Hughes C
    Clin Infect Dis; 1995 Nov; 21(5):1328-9. PubMed ID: 8589170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
    Svecová D; Buchvald J; Oprsalová K; Dolezalová A
    Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):115-22. PubMed ID: 11040493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guillain-Barré syndrome in a course of early cutaneous type of Lyme borreliosis: diagnostic and therapeutic difficulties].
    Wiszniewska M; Szmaglińska H; Kozubski W
    Neurol Neurochir Pol; 2005; 39(5):412-6. PubMed ID: 16273467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B; Glatz M; Kerl H; Müllegger RR
    Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of 10 cases of Lyme disease presenting with erythema migrans in Istanbul, Turkey].
    Akın Belli A; Derviş E; Özbaş Gök S; Midilli K; Gargılı A
    Mikrobiyol Bul; 2015 Oct; 49(4):525-31. PubMed ID: 26649410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Southern tick-associated rash illness: erythema migrans is not always Lyme disease.
    Blanton L; Keith B; Brzezinski W
    South Med J; 2008 Jul; 101(7):759-60. PubMed ID: 18580719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.
    Strle F; Maraspin V; Lotric-Furlan S; Ruzić-Sabljić E; Cimperman J
    Infection; 1996; 24(1):64-8. PubMed ID: 8852473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borrelia lonestari infection after a bite by an Amblyomma americanum tick.
    James AM; Liveris D; Wormser GP; Schwartz I; Montecalvo MA; Johnson BJ
    J Infect Dis; 2001 Jun; 183(12):1810-4. PubMed ID: 11372036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.